SGRX (Sangrix) Beta: 4.7493 (As of Sep. 06, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SGRX Sangrix Inc SGRX
13 GF Score
Price $2.08
GF Value $0.47
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Sangrix Beta?

Sangrix SGRX -2.64% 13 Beta is 4.7493 as of Sep. 06, 2026. GuruFocus rates SGRX with a GF Score™ of 13/100 and a GF Value™ of $0.47 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-09-06), Sangrix's Beta is 4.7493.


Sangrix  (NAS:SGRX) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Sangrix Beta Related Terms


Sangrix Beta Historical Data

* Premium members only.

The historical data trend for Sangrix's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sangrix Beta Chart

Sangrix Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.17 2.11 2.58

Sangrix Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.20 2.11 2.63 2.58 5.56

SGRX vs QMCI, SPGI, CME: Beta Comparison

For the Information Technology Services subindustry, Sangrix's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sangrix Beta vs Software Industry

For the Software industry and Technology sector, Sangrix's Beta distribution charts can be found below:

* The bar in red indicates where Sangrix's Beta falls into.


SGRX
13GF Score
Sangrix Inc SGRX
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sangrix Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 4.7493 mean?
Sangrix (SGRX) has a Beta of 4.7493 as of Sep. 06, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Sangrix and its competitors.
Is Sangrix's Beta too high?
Sangrix's current Beta is 4.7493. Overall, Sangrix has a GF Score™ of 13/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sangrix's Beta compare to QMCI and SPGI?
Sangrix's Beta of 4.7493 can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Software company?
A good Beta depends on the Software industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Sangrix and its competitors. Sangrix's current Beta is 4.7493. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sangrix stock overvalued right now?
Based on GuruFocus' analysis, Sangrix (SGRX) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.47, compared to a current price of $2.08 — trading 341.5% above its estimated fair value. The current Beta is 4.7493. Sangrix's overall GF Score™ is 13/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Sangrix (SGRX), the current Beta is 4.7493 as of Sep. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sangrix (SGRX) Overvalued in 2026?

Based on GuruFocus' analysis, Sangrix stock appears to be overvalued. The current stock price of $2.08 is trading 341.5% above its estimated GF Value™ of $0.47. GuruFocus considers Sangrix to be Significantly Overvalued.

Key valuation signals for SGRX:

  • Beta: 4.7493
  • GF Value™: $0.47 vs. price of $2.08 (341.5% above fair value)
  • GF Score™: 13/100 with 6 warning signs

No single metric tells the full story. See the SGRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sangrix Business Description

Address 160 Robinson Road, 12th Floor, SBF Center, Singapore, SGP, 068914
Bit Origin Ltd is seeking opportunities in deploying new technologies, crypto asset mining and blockchain technologies in Singapore. The company has focused on building the Bitcoin mining ecosystem through incubations, strategic investments, and acquisitions. It derives all of its revenue from Bitcoin mining.
13GF Score

Get the complete analysis for SGRX

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.08
Price
$0.47
GF Value